- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01918449
Follow-up of Patients With Obstructive Sleep Apnea in Primary Care.
Follow-up of Patients With the Apnea-hypopnea Syndrome in Primary Care and Sleep Disorders Units. Equivalence Randomized Comparative Study on Compliance and Clinical Response.
The objective of the study is to compare the results of a coordinated and interactive program for the treatment, monitoring and control of patients with a moderate-severe diagnosis of Obstructive Sleep Apnea (OSA) and treated with positive continuous pressure (CPAP), with the currently established situation.
Methodology: Equivalence randomized comparative study . It will include patients with diagnosis of moderate-severe OSA (apnea-hypopnea Index >=15) that should start treatment with (CPAP). Participating center is Hospital Santa María-Arnau de Vilanova in Lleida (Spain).These patients will be randomized to two monitoring groups (1: monitoring in the Sleep disorders unit, 2: monitoring in primary care consultations) once the OSAS diagnosis has been made and it was indicated that treatment with CPAP. Patients Will be carried out in both groups the same follow-up visits in two study arms: basal, 1 month, 3 months and 6 months. Primary outcomes: number of hours of use per day (according to the accountant of the CPAP), so that use >= 4h/day is defined as good adherence to the treatment. Secondary outcomes: daytime sleepiness, patient satisfaction, Adverse events related to CPAP treatment. It will be collected demographic ,clinics and anthropometric variables. At the end of follow-up primary and secondary outcomes will be compared between two groups.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Catalonia
-
Lleida, Catalonia, Spain, 25198
- Hospital Santa Maria
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Men and women over 18 years old.
- Patients with OSA diagnosis performed in the sleep units
- Written informed consent signed.
Exclusion Criteria:
- Previous CPAP treatment for OSA diagnosis
- Psycho-physical inability to complete questionnaires.
- Presence of any previously diagnosed sleep disorders: narcolepsy, insomnia, chronic sleep deprivation, regular use of hypnotic or sedative medications and restless leg syndrome
- Patients with respiratory diseases (overlap syndrome, hypoventilation, restrictive diseases)
- A medical history that may interfere with the study objectives or, in the opinion of the investigator, compromise the conclusions.
- Any medical factor, social or geographical, that may jeopardize patient compliance.(e.g., alcohol consumption (more 80 gr/day in men and more than 60 gr / day in women), no fixed address, disorientation, or a history of non-compliance).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Sleep Unit group
This group will have standard follow up in sleep unit at 1, 3 and 6 month.
These patients will also be instructed in hygienic-dietary measures, standard care of cardiovascular risk factors and sleep hygiene counseling.
|
|
Experimental: Primary Care group
This group will have standard follow up in primary care at 1, 3 and 6 month.
These patients will also be instructed in hygienic-dietary measures, standard care of cardiovascular risk factors and sleep hygiene counseling.
|
The study evaluates two different setting to follow up patients with obstructive sleep apnea on CPAP treatment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of hours of use per day of CPAP
Time Frame: Six month
|
Number of hours of use per day of CPAP according to the internal clock of the CPAP device
|
Six month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Daytime sleepiness
Time Frame: At baseline and at 6 month of follow-up
|
Epworth Sleepiness Scale (ESS)
|
At baseline and at 6 month of follow-up
|
Patient satisfaction
Time Frame: Six month
|
visual analog scale (0-10)
|
Six month
|
Adverse events
Time Frame: Six month
|
Adverse events related to CPAP treatment
|
Six month
|
Quality of life
Time Frame: Baseline and at 6 month of follow up
|
EuroQol
|
Baseline and at 6 month of follow up
|
Cost-efficacy evaluation
Time Frame: Six month
|
Qualys
|
Six month
|
Comorbidity index
Time Frame: Six month
|
Charlson index
|
Six month
|
Blood pressure
Time Frame: Sixt month
|
Office blood pressure
|
Sixt month
|
Lost of follow up
Time Frame: Six month
|
Percentage of patients lost during follow up
|
Six month
|
Other Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Body mass index
Time Frame: Six month
|
Six month
|
Collaborators and Investigators
Investigators
- Study Director: Ferran Barbe, MD, Hospital Anrnau Vilanova- Santa Maria, Lleida (Spain)
- Principal Investigator: Cristina Esquinas, RN, MPH, Hospital Arnau Vilanova-Santa Maria, Lleida (Spain)
- Principal Investigator: Nuria Nadal, MD, Primary Care. National Health Institute. Lleida (Spain)
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- PI12/01499
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on OSA
-
Biocubica srlRecruiting
-
Brigham and Women's HospitalRecruiting
-
Brigham and Women's HospitalRecruiting
-
Woolcock Institute of Medical ResearchFullpower Technologies, Inc.Not yet recruiting
-
Chang Gung Memorial HospitalUnknown
-
Mahidol UniversityUnknownOSA | ComplicationThailand
-
Changi General HospitalCompleted
-
VA Office of Research and DevelopmentRecruitingOSA | COPDUnited States
Clinical Trials on Clinical follow up by general practitioners in primary care
-
Hospital Universitario ArabaLinde Health Care; Spain:Health Department. Basque Government.Completed
-
Kaiser PermanenteThe Permanente Medical GroupCompleted
-
Hospital Moinhos de VentoNot yet recruiting
-
Nantes University HospitalUniversity Hospital, Strasbourg, France; University Hospital, Clermont-Ferrand and other collaboratorsActive, not recruitingSingle or Dual Chamber Pacemaker Implantation | Home Monitoring Follow-upFrance
-
Ohio State University Comprehensive Cancer CenterNot yet recruitingBreast Carcinoma | Breast Atypical Ductal Hyperplasia | Breast Atypical Lobular Hyperplasia | Breast Lobular Carcinoma In Situ | Breast Sclerosing AdenosisUnited States
-
Prince of Songkla UniversityCompletedCommon Bile Duct CalculiThailand
-
Women's College HospitalCanadian Institutes of Health Research (CIHR)CompletedUse of Mobile App Home Monitoring After Ambulatory SurgeryCanada
-
Haukeland University HospitalUllevaal University Hospital; Stiftelsen Helse og RehabiliteringCompletedTraumatic Brain Injury With Brief Loss of ConsciousnessNorway
-
Norwegian University of Science and TechnologyThe Research Council of Norway; Asker & Baerum Hospital; St. Olavs Hospital; Helse...Completed
-
Castilla-La Mancha Health ServiceColegio Oficial de Terapeutas Ocupacionales de Castilla - La Mancha; Fundación... and other collaboratorsRecruiting